Skip to main content
Elsevier

Journals in Oncology

Focusing on tumor biology, diagnostics, and targeted therapies, this portfolio supports oncologists, researchers, and clinicians. It features innovations that improve cancer detection, personalized treatments, and survivorship care.

  • Current Advances in Cancer Research

    • ISSN: 0895-9803
    Subscriptions

  • The Lancet Oncology

    • ISSN: 1470-2045
    The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.
    Subscriptions

  • The Lancet Haematology

    • ISSN: 2352-3026
    The Lancet Haematology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, review, and opinion covering international issues, providing a clear, independent perspective about the clinical advances and practice-changing research shaping clinical haematology.The Lancet Haematology is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology... red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.
    Subscriptions

  • The Lancet

    • ISSN: 0140-6736
    The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
    Subscriptions

  • Magnetic Resonance Imaging

    • ISSN: 0730-725X
    An International Journal of Basic Research and Clinical ApplicationsMagnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
    Subscriptions

  • Cancer Epidemiology

    • ISSN: 0361-090X
    Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).
    Subscriptions

  • Cancer Epidemiology

    • ISSN: 1877-7821
    Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).
    Subscriptions

  • Cancer Treatment Reviews

    • ISSN: 0305-7372
    Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Journal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • Journal of Thoracic Oncology

    • ISSN: 1556-0864
    Official Journal of the International Association for the Study of Lung CancerAbout the JournalJournal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.Authors are also welcome to submit to the journal's open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
    Subscriptions

  • Radiotherapy & Oncology

    • ISSN: 0167-8140
    Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology.Radiotherap... and Oncology, also known as the Green journal, aims at driving innovation in radiation oncology. It publishes high impact articles describing original research as well as review articles. It covers all areas of interest relating to clinical radiotherapy and oncology, medical physics, radiation biology, as well as other areas relevant to the radiation oncology community such as education, health policy, environmental and societal sustainability or health economics. The journal has a particular interest in prospective clinical trials or large population-based database analyses. It also looks to publish works related to: clinical radiotherapy and brachytherapy, combined modality treatment (for example with chemotherapy, surgery and immunology), particle therapy, translational and experimental radiotherapy and radiation biology, medical physics, imaging, dosimetry, and radiation therapy planning, data science and artificial intelligence research relevant to radiotherapy.ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
    Subscriptions